DAWN Day One Biopharmaceuticals, Inc.: institutional ownership and insider trading
Over the last 12 months insiders bought $0 and sold $672K on the open market.
Recent DAWN insider trades
- Feb 17, 2026: York Charles N II sold 6,065 shares ($70.4K)
- Feb 17, 2026: Vasconcelles Michael sold 2,728 shares ($31.6K)
- Feb 17, 2026: Dubow Adam sold 6,395 shares ($74.2K)
- Feb 17, 2026: Merendino Lauren sold 5,814 shares ($67.4K)
5%+ owners
- BlackRock, Inc.: 5.8% (Schedule 13G, filed Jul 17, 2025)
- Glazer Capital, LLC: 5.4% (Schedule 13G, filed Mar 19, 2026)